The development of synthetic peptidolipids, glycolipids and other lipid-linked structures to create designer red cells

aut.relation.endpage195A
aut.relation.issue2
aut.relation.startpage194A
aut.relation.volume48
aut.researcherHenry, Stephen Micheal
dc.contributor.authorHenry, S
dc.contributor.authorBovin, N
dc.date.accessioned2012-05-13T20:31:05Z
dc.date.available2012-05-13T20:31:05Z
dc.date.copyright2008-09
dc.date.issued2008-09
dc.description.abstractBackground: Red cells used in immunohematology assays are restricted by their natural phenotype and membrane characteristics. More recently a technology has been developed which allows for the attachment of a large variety of specific carbohydrates, peptides and other structures to the surface of cells – known as FSL cell surface coating (KODETM technology). FSL constructs are water dispersible and consist of three components; a F functional head group, a S spacer and a L diacyl lipid tail. This technology allows users to introduce novel antigen profiles or characteristics at the membrane surface of cells. Methods: FSL constructs were synthesised bearing carbohydrates, peptides, and fluorophores. One part (0.05 ml) of FSL construct 1 mg/ml and one part of packed red cells were combined, mixed and incubated at 37°C for 2 hours, washed and then analysed for the presence of constructs by direct-indirect agglutination and fluorescence serological methods. Results: In all cases red cells were shown to be able to be precisely labelled with serologically detectable FSL construct. Red cells were modified to carry ABO, H, Lewis, acquired-B, the animal antigen Galili, hyaluronic acid, fluorophores and blood group peptides (Miltenberger). Conclusion: FSL cell surface coating technology allows for the creation of red cells expressing controlled levels of normal and/or novel antigens or structures. Such cells can be used for quality control, specialised antibody screening and identification panels and have potential for novel future applications.
dc.identifier.citationTransfusion 2008; 48 (2S) Suppl.: 194A
dc.identifier.doi10.1111/j.1537-2995.2008.01891.x
dc.identifier.issn0041-1132
dc.identifier.urihttps://hdl.handle.net/10292/4136
dc.publisherJohn Wiley & Sons
dc.rightsCopyright © 2008 John Wiley & Sons. All rights reserved. Authors retain the right to place his/her pre-publication version of the work on a personal website or institutional repository. This article may not exactly replicate the final version published in (please see citation) as it is not a copy of this record. An electronic version of this article can be found online at: (Please see Publisher’s Version)
dc.rights.accessrightsOpenAccess
dc.titleThe development of synthetic peptidolipids, glycolipids and other lipid-linked structures to create designer red cells
dc.typeConference Contribution
pubs.organisational-data/AUT
pubs.organisational-data/AUT/Health & Environmental Science
pubs.organisational-data/AUT/PBRF Researchers
pubs.organisational-data/AUT/PBRF Researchers/Health & Environmental Sciences PBRF Researchers
pubs.organisational-data/AUT/PBRF Researchers/Health & Environmental Sciences PBRF Researchers/HES Applied Science
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2008 AABB abstract SP469 Henry .pdf
Size:
46.98 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
licence.htm
Size:
29.98 KB
Format:
Unknown data format
Description: